Spots Global Cancer Trial Database for cdk4
Every month we try and update this database with for cdk4 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma | NCT04238819 | Relapsed Solid ... Refractory Soli... | Abemaciclib Irinotecan Temozolomide Dinutuximab GM-CSF | - 21 Years | Eli Lilly and Company | |
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | NCT02571829 | Liposarcoma Soft Tissue Sar... | ribociclib | 18 Years - | Hadassah Medical Organization | |
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. | NCT03283384 | Breast Neoplasm... | Letrozole Chemotherapy Ribociclib plus... | 18 Years - | Borstkanker Onderzoek Groep | |
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer | NCT02763566 | Breast Cancer | Abemaciclib Anastrozole Letrozole Placebo Fulvestrant | 18 Years - | Eli Lilly and Company | |
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | NCT02571829 | Liposarcoma Soft Tissue Sar... | ribociclib | 18 Years - | Hadassah Medical Organization | |
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. | NCT03242382 | Soft-tissue Sar... Osteosarcoma Chordoma | Palbociclib | 18 Years - 80 Years | Grupo Espanol de Investigacion en Sarcomas |